A new study reveals coronavirus patients who were severely ill with COVID-19 were 45% less likely to die after being given the drug tocilizumab, an interleukin-6 receptor inhibitor, that has used to treat arthritis.

Original source: https://www.newsmax.com/health/anti-aging/tocilizumab-drug-covid-19-pandemic/2020/06/04/id/970614